...
首页> 外文期刊>Biochemistry >Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I
【24h】

Deciphering Conformational Changes Associated with the Maturation of Thrombin Anion Binding Exosite I

机译:与凝血酶阴离子结合后的凝血酶阴离子的成熟相关的构象变化

获取原文
获取原文并翻译 | 示例
           

摘要

Thrombin participates in procoagulation, anticoagulation, and platelet activation. This enzyme contains anion binding exosites, ABE I and ABE II, which attract regulatory biomolecules. As prothrombin is activated to thrombin, pro-ABE I is converted into mature ABE I. Unexpectedly, certain ligands can bind to pro-ABE I specifically. Moreover, knowledge of changes in conformation and affinity that occur at the individual residue level as pro-ABE I is converted to ABE I is lacking. Such changes are transient and were not captured by crystallography. Therefore, we employed nuclear magnetic resonance (NMR) titrations to monitor development of ABE I using peptides based on protease-activated receptor 3 (PAR3). Proton line broadening NMR revealed that PAR3 (44–56) and more weakly binding PAR3G (44–56) could already interact with pro-ABE I on prothrombin. 1H–15N heteronuclear single-quantum coherence NMR titrations were then used to probe binding of individual 15N-labeled PAR3G residues (F47, E48, L52, and D54). PAR3G E48 and D54 could interact electrostatically with prothrombin and tightened upon thrombin maturation. The higher affinity for PAR3G D54 suggests the region surrounding thrombin R77a is better oriented to bind D54 than the interaction between PAR3G E48 and thrombin R75. Aromatic PAR3G F47 and aliphatic L52 both reported on significant changes in the chemical environment upon conversion of prothrombin to thrombin. The ABE I region surrounding the 30s loop was more affected than the hydrophobic pocket (F34, L65, and I82). Our NMR titrations demonstrate that PAR3 residues document structural rearrangements occurring during exosite maturation that are missed by reported X-ray crystal structures.]]>
机译:<![cdata [ src ='http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/bichaw/2017/bichaw.2017.56.issue-48/acs.biochem.7b00970/ 20171129 /图像/介质/ BI-2017-00970Z_0009.gif“>凝血酶参与Procoagulation,抗凝和血小板激活。该酶含有阴离子结合的exosites,Abe I和Abe II,其吸引调节生物分子。随着凝血酶原激活为凝血酶,Pro-Abe I被转化为成熟Abe I.意外地,某些配体可以具体结合Pro-abe。此外,作为Pro-abe I作为Pro-abe I的各个残留水平发生的构象和亲和力变化的知识被转换为ABE I缺乏。这种变化是瞬时的,并且没有通过晶体学捕获。因此,我们使用核磁共振(NMR)滴定来监测基于蛋白酶活化受体3(PAR3)的肽的ABE I的开发。质子线展现NMR显示,PAR3(44-56)和更弱的PAR3G(44-56)可以已经与凝血酶原上的Pro-abe I相互作用。 1 h- 15 n异核单量子相干NMR滴定,用于探测单个 15℃的N-标记的pAR3g残基(F47, E48,L52和D54)。 PAR3G E48和D54可以用凝血酶素静电和静电凝血酶拧紧。对PAR3G D54的较高亲和力表明,凝血酶R77A周围的区域更好地取向D54,而不是PAR3G E48和凝血酶R75之间的相互作用。芳族PAR3G F47和脂族L52既报告了在凝血酶上转化为凝血酶时化学环境的显着变化。 30S回路周围的ABE I区域比疏水袋(F34,L65和I82)更受影响。我们的NMR滴定表明,PAR3残留物文件在X射线晶体结构中错过的过后成熟期间发生的结构重排。]]>

著录项

  • 来源
    《Biochemistry》 |2017年第48期|共12页
  • 作者单位

    Department of Chemistry University of Louisville Louisville Kentucky 40292 United States;

    Department of Medicine James Graham Brown Cancer Center University of Louisville Louisville Kentucky 40202 United States;

    Department of Medicine James Graham Brown Cancer Center University of Louisville Louisville Kentucky 40202 United States;

    Department of Chemistry University of Louisville Louisville Kentucky 40292 United States;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号